PipelinePharma Logo

sevoflurane Inhalation vapour 250 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Unavailable markets
Netherlands , Spain , Philippines
Registered in
Spain , Netherlands
Available for
Licensing with supply, Distribution only
Manufacturer #22243
This technology-driven company specializes in pharmaceutical research and development, regulatory registration, trading, and industrial investment. Their product portfolio encompasses chemical generic drugs (including APIs), biological products, and plasma products. Key therapy areas include central nervous system disorders, diabetes, infectious diseases, and cardiovascular conditions. They offer a range of dosage forms including tablets, injections, and intermediates.The company serves customers across the EU, North America, and other regions through a global network. Their commitment to quality is demonstrated by their adherence to Good Manufacturing Practices (GMP) certifications. They hold several patents for their products and provide services such as regulatory affairs consultation and technology transfer.

Manufacturer usually replies in 7 days

Sevoflurane is a fast-acting inhalable anesthetic agent that is used to induce sleep for patients before surgery. It is marketed as a liquid solution that is turned into vapor and administered to patients orally. Inhalable anesthesia is reportedly associated with lower risks of adverse effects and is more cost-effective than anesthetics that have an intravenous route of administration. And sevoflurane accounts for approximately two-thirds of global inhalable anesthetic drug market share. This is primarily due to its satisfactory effectiveness and lower price. Isoflurane and desflurane – the two primary substitutes in this drug class are typically selected over sevoflurane when there is a need for prolonged maintenance of anesthesia for the patient. Currently, sevoflurane is available in over 120 countries worldwide, with the most popular trade name sevoflurane agent (Ultane) having been used on over 1 billion patients throughout the past 25 years. Its widespread use notwithstanding, most of the global inhalable anesthesia market is split between a limited number of manufacturers and suppliers. The largest suppliers of sevoflurane liquid solutions are AbbVie, Baxter, and Lunan Pharmaceutical. The retail price per 250ml sevoflurane liquid solution is approximately 150-250 EUR.